Malta vs Paraguay: The number of people with susceptibility test result for rifampicin
Malta
93.1
in 2021
Paraguay
92.7
in 2021
Malta rank
59th
Paraguay rank
60th
The number of people with susceptibility test result for rifampicin over time
- Malta
- Paraguay
How they compare
Malta currently reports 93.1 against 92.7 in Paraguay, a difference of 0.4.
Across all 5 years both countries report, Malta has been ahead every year.
Malta ranks 59th and Paraguay ranks 60th of 146 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.41 | 42.23 | 49.18 | Malta |
| 2020s | 90.14 | 74.59 | 15.55 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or Paraguay?
- Malta, at 93.1 against 92.7 in Paraguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and Paraguay?
- 0.4, with Malta ahead.
- How many years of comparable data are there for Malta and Paraguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and Paraguay rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 59th and Paraguay ranks 60th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.